Back
ESC Premium Access

Blood pressure and white matter lesions in patients with atrial fibrillation

Session: Atrial fibrillation: from drugs to ablation
Topic: Epidemiology, Prognosis, Outcome
Speaker: Associate Professor D. Conen (Hamilton, CA)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Associate Professor David Conen

Population Health Research Institute, Hamilton (Canada)
4 presentations
1 follower

3 more presentations in this session

Direct oral anticoagulant rivaroxaban in very old and frail patients: A one-year prospective follow-up of a large-scale cohort (SAFIR-AC)

Speaker: Professor O. Hanon (Paris, FR)

Access
Abstract
Slides
Video
Thumbnail

Impact of AF type on the outcome of atrial fibrillation ablation: insights from the CABANA trial

Speaker: Assistant Professor K. Monahan (Rochester, US)

Access
Abstract
Slides
Video
Thumbnail

Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study

Speaker: Professor L. Fauchier (Tours, FR)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Atrial fibrillation: from drugs to ablation

Speakers: Associate Professor D. Conen, Professor O. Hanon, Assistant Professor K. Monahan, Professor L. Fauchier
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb